Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, November 6, 2026

Back to the front page

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M
Nat Stewart - Stock Picking Newsletter 23 clicks

From X

@StableBread

Fajasy on X

The Pentagon wants every major U.S. military installation to generate its own power. In August 2026, the Army chose five companies for Janus, a program expected to put more than 20 commercial microreactors on military bases. One of the five already builds the reactors for the Navy’s submarines and aircraft carriers, and its stock is down almost 40%. That company is BWX Technologies $BWXT, and even after a 7.6% jump on October 6, the stock is down 38.9% from its $238.42/share peak on April 15. $BWXT didn’t fall alone: → The VanEck Uranium and Nuclear ETF $NLR is down 33.4% from its January high, even after rising 5.5% on October 6. → Curtiss-Wright $CW, which supplies pumps and valves for the same submarines and carriers, is down 30.2% from its July high. So $BWXT got caught in a broader nuclear and defense selloff, but it fell further than both $NLR and $CW after guiding to slower growth in 2027. Meanwhile, $BWXT’s business got stronger: → Guidance up twice: 2026 adjusted EBITDA guidance rose from $645-660M in February to $662-672M in August. → An $8.4B backlog, more than double the $4.0B $BWXT had at the end of 2023. → CEO Rex Geveden calls $BWXT “the sole provider for naval reactors.” The Navy’s 30-year shipbuilding plan, released in May, calls for a new carrier every four years instead of every five. → The Army chose $BWXT’s 20-megawatt reactor for Janus at Fort Campbell, Kentucky, on August 26. On October 5, Prodigy Clean Energy, a Montreal-based developer of factory-built nuclear plants, chose the same reactor for a transportable power plant in New Brunswick. → 2030 targets: $BWXT targeted $5.5-6.0B of revenue and $1.1-1.2B of adjusted EBITDA in 2030. It’s on track to meet or beat all three targets it set in February 2024. Still, here’s what could hold the stock back: → $BWXT expects growth to slow in 2027. Its preliminary framework calls for high-single-digit growth in both revenue and adjusted EBITDA. → Even after the 38.9% drop, $BWXT isn’t cheap in absolute terms. It trades at 20.9x NTM EV/EBITDA and 29.3x earnings. → By CFO Mike Fitzgerald’s count, only a little over half of the revenue growth to 2030 comes from what $BWXT calls its “predictable core,” the programs backed by backlog and long-term contracts. The rest depends on new orders and acquisitions. → $BWXT’s Janus release discloses no dollar figure. Owning reactors is a new business model for $BWXT, with capital commitments it hasn’t disclosed. → No $BWXT insider has bought stock in the open market since at least January 2025, including during the drop from $238 to $135. → The government is running on a continuing resolution through December 11. At $145.70/share, BWXT has a market cap of $13.35B and an EV of $15.0B ($13.35B + $2.05B of debt - $0.40B of cash). It trades at 22.5x 2026 adjusted EBITDA guidance and 30.7x non-GAAP EPS guidance. In return, you get an $8.4B backlog, more than double the $4.0B BWXT had at the end of 2023. And on NTM estimates, its EV/EBITDA has dropped to 20.9x from ~35x in March, back to its 2024 levels. So is the Navy’s reactor supplier on sale, or does the market see a slowdown the numbers don’t show yet? That's what I answer in my new ~6,800 word deep dive on $BWXT! Credit to @GrumpierBTDay for the idea.

Investor Letters

All letters

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M
The Oak Bloke 2 clicks
AAP · long

Advance Auto Parts INC

Advance Auto Parts, AAP, is presented as a long idea following prior write-ups at $48.81 per share in January 2025.

AAP $2.9B
Value Investors Club 1 click

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Research Note

Nine Mile Metals is the subject of a research note.

VMSXF $14M
Atrium Research - Equity Research 4 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 278

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.